SOPHiA GENETICS Names New President, Chief Financial Officer

Dow Jones
2024-11-05
 

By Colin Kellaher

 

SOPHiA GENETICS on Tuesday unveiled a pair of C-suite changes that include the hiring of a new chief financial officer.

SOPHiA said Ross Muken, who had been chief financial and operating officer of the Switzerland-based healthcare-technology company, is taking on the newly created role of president, overseeing its global business operations and working more closely on strategic planning with Chief Executive Jurgi Camblong.

SOPHiA said George Cardoza, most recently finance chief and head of service delivery at molecular-diagnostics company Biocartis, has joined the company as chief financial officer.

 

Write to Colin Kellaher at colin.kellaher@wsj.com

 

(END) Dow Jones Newswires

November 05, 2024 07:25 ET (12:25 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10